Wolverine Trading
SCPH

Wolverine Trading’s scPharmaceuticals SCPH Stock Holding History

Wolverine Trading’s Portfolio SCPH Stock Details SCPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Hold
0
– – – 6729
2024
Q1 		– Sell
-19,726
Closed -$124K – 5723
2023
Q4 		$124K Buy
+19,726
New +$113K ﹤0.01% 4050
2023
Q3 		– Hold
0
– – – 5680
2023
Q2 		– Hold
0
– – – 5541
2022
Q4 		– Sell
-23,282
Closed -$141K – 5525
2022
Q3 		$141K Buy
23,282
+9,512
+69% +$50.8K 0.01% 3782
2022
Q2 		$68K Buy
+13,770
New +$68.1K ﹤0.01% 3970

Other funds holding SCPH

O
OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $8.16B AUM 68.42% 1-Year Est. Return
WAM
Weiss Asset Management Boston, Massachusetts $5.43B AUM 42.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $18.6B AUM 29.12% 1-Year Est. Return
Luther King Capital Management (LKCM)
Luther King Capital Management (LKCM) Fort Worth, Texas $23.1B AUM 21.31% 1-Year Est. Return
HSBC Holdings
HSBC Holdings London, United Kingdom $168B AUM 27.2% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return